Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
This study is ongoing, but not recruiting participants.
Study NCT00075686
Information provided by National Cancer Institute (NCI)
First Received: January 9, 2004
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
